OverviewChartTechnicalNewsTraderScreen

Zai Lab Ltd/  US98887Q1040  /

NASDAQ
7/15/2024  10:00:00 PM Chg. -0.0400 Volume Bid11:21:21 AM Ask11:21:21 AM High Low
18.0000USD -0.22% 455,821
Turnover: 6.28 mill.		 17.0000Bid Size: 400 17.9900Ask Size: 100 18.2300 17.5450
GlobeNewswire 6/1 Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...
GlobeNewswire 5/9 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 4/18 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire 4/10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 3/6 Crescendo Biologics to present at the 2024 AACR Annual Meeting
GlobeNewswire 3/5 Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of...
GlobeNewswire 2/29 argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire 2/14 Genmab Publishes 2023 Annual Report
GlobeNewswire 1/16 Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire 1/8 argenx Highlights 2024 Strategic Priorities
GlobeNewswire 1/4 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 12/13/2023 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire 12/6/2023 Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307...
GlobeNewswire 11/7/2023 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 10/31/2023 argenx Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 10/26/2023 Zai Lab Announces Participation in November Investor Conferences
GlobeNewswire 10/18/2023 Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire 10/5/2023 Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
GlobeNewswire 9/21/2023 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire 9/18/2023 Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and No...
GlobeNewswire 9/18/2023 Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injec...
GlobeNewswire 9/12/2023 Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockh...
GlobeNewswire 9/7/2023 Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR...
GlobeNewswire 9/4/2023 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 8/30/2023 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patien...